Inhibin B (INHBB), a heterodimer of a common α-subunit and a βB-subunit, is a glycoprotein belonging to the transforming growth factor-β (TGF-β) family. In this study, we observed INHBB expression was reduced in nasopharyngeal carcinoma 
| INTRODUCTION
Nasopharyngeal carcinoma is a head and neck cancer derived from the epithelium of the nasopharynx, which is associated with EBV infection and is highly invasive and metastatic. The NPC population is mainly distributed in Southeast Asia, especially in southern China.
Although treatment outcomes have improved with technological developments, metastasis and recurrence are still the main causes of death. Therefore, it is crucial to clarify the mechanisms of NPC metastasis. It has been shown that anoikis resistance was involved in NPC metastasis, and reducing the anoikis-resistant capacity of NPC cells could reverse their invasive properties. 1 Anoikis is a specific programmed cell death from the ECM, which is conducive to physical development and balance. It is the primary condition of invasion and metastasis for the characteristics of anoikis resistance in tumor cells, attributed to changes in cell polarity 2 and the induction of EMT. 3 Anoikis inhibition confers a re-adhesion ability to tumor cells in heterogeneous tissues and organs, therefore, anoikis is considered to be a prerequisite for survival of metastatic tumor cells in the circulation system. 4, 5 As one of the highly metastatic tumors, NPC reportedly has anoikis resistance. 6 Manganese superoxide dismutase could regulate the anoikis resistance and tumor metastasis in NPC, 7 however, the related mechanisms have rarely been addressed.
Inhibin, a heterodimer formed by a disulfide linkage of an α-subunit and a β-subunit, is a kind of glycoprotein hormone that is mainly secreted by ovarian granulosa cells and testicular Sertoli cells. Inhibin belongs to member of the TGF-β family. Inhibin B, which is mainly composed of α-subunits and βB-subunits and has a 32 × 10 3 relative molecular weight, suppresses the secretion of the pituitary folliclestimulating hormone by the negative feedback mechanism, and regulates the generation of follicle. The knockdown INHBB granule cells upregulated cell cycle protein D1, E, and Bcl2 expression and downregulated Bax expression, which could promote cell apoptosis and block the cell cycle in the G 1 phase. 8 In recent studies, it has been reported to affect the development and prognosis of ovarian cancer, 9 colorectal cancer, 10 and breast cancer 11 because INHBB influences DNA synthesis.
Our pilot studies of preliminary experiments showed that INHBB mRNA presented the negative signal in major NPC tissues, INHBB expression was downregulated in NPC tissues. In addition, INHBB was negatively correlated with lymph node metastasis, histologic type, clinical progression, tumor size, and invasive range. Studies showed that the loss of inhibin responsiveness generated stronger aggressive tumorigenicity of ovarian cancer cells 12 and inhibins were tumor suppressors in peripheral tissues. South University (Changsha, China). The patients' mean age was 48 years (range, 13-78 years). All subjects provided their informed consent. The specimens were fixed with 10% polyformaldehyde, which were made into paraffin samples. After pathological diagnosis, the selected tissue samples were prepared for the examination of the TMA of NPC. The TMA of different stages of NPC was constructed according to our previous study. 14, 15 Immunohistochemistry was carried out using a standard procedure as previously described. 15 Inhibin B was detected using rabbit polyclonal antibody at a 1:100 dilution. The results were observed by optical microscope (E600; Nikon, Tokyo, Japan 
| Cell culture and reagents
Two highly metastatic NPC cell lines, HNE1 and 5-8F, were supplied by the Central South University Advanced Research Center. The NPC cell lines were cultured in medium containing 15% FBS (Gibco, Rio De Janeiro, Brazil), RPMI-1640 medium (Gibco, Beijing, China), and 100 U/mL penicillin-streptomycin (Gibco, Carlsbad, CA, USA), in 5% CO 2 and 95% O 2 in a 37°C culture incubator (Thermo Fisher Scientific, Marietta, Ohio, USA). Cell growth covered 70%-80% of the area, digested by 0.25% trypsin-EDTA (Gibco, Carlsbad, CA, USA), and the culture was transferred every 24 hours. The RIPA lysis buffer and BCA protein quantitation assay kit were purchased from KeyGEN BioTECH (Nanjing, China).
| Preparation for anoikis-resistant culture plates
Ten grams of poly-(2-hydroxyethyl methacrylate) HEMA powder (25249-16-5; Sigma, St. Louis, MO, USA) was dissolved in 100 mL of 95% alcohol (100 mg/mL), vibrated until completely dissolved, then diluted four times into 25 mg/mL with 95% alcohol. One milliliter per well of liquid was coated for a 6-well plate, 0.5 mL/well was coated for a 24-well plate, and 100 μL/well was coated for a 96-well plate.
Package plates were placed at room temperature in a bio-safety cabinet, dried for 24 hours, and irradiated by UV radiation before use. 
| Cell transfection
The The experimental cells were divided into three groups: normal control group (no intervention treatment), overexpression and negative control group transfection (INHBB/Vector), and interference and negative control group (INHBB shRNA/NC shRNA).
| Detection of cell apoptosis and cell cycle by flow cytometry
The experimental cells were cultured with free-serum culture medium for 12 hours, and the cell growth cycle was synchronized. We adjusted the cell number of single-cell suspension to 1-5 × 10 6 /mL.
After centrifugation, the supernatant liquid was discarded, and cells were stained with propidium iodide (PI 
| Western blot analysis
The experimental cells of the same growth time and good condition were collected. After washing with ice-cold PBS, cells were added to the RIPA lysis buffer for 20 minutes. After centrifuged (13 188 g) with 4°C, protein was determined using a BCA protein assay kit.
Western blotting was carried out according to standard protocol. 
| Statistical analysis
Data were analyzed with SPSS 16.0 (SPSS, Chicago, IL, USA). Student's t test was applied for comparison of the differences between two groups, one-way ANOVA was used to evaluate multiple groups, the clinicopathological parameters were analyzed by the χ 2 test or
Fisher's exact test, event-free survival and overall survival were plotted by Kaplan-Meier survival curves, and GraphPad Prism 5.0 (GraphPad Software, La Jolla, CA, USA). P ≤ 0.05 indicated statistical significance.
| RESULTS

| Inhibin B downregulated in nasopharyngeal carcinoma tissues and associates with clinical prognosis
We previously detected the INHBB expression levels in a TMA using 
| Anoikis-resistant cell establishment
The 
| Anoikis-resistant cells change EMT markers and the cell cycle
Under the microscope, the suspension cells were clustered, and the boundary was not clear. The re-adhesion anoikis-resistant cells were evacuated and dwindled ( Figure 2C ). Due to cell deformation, we questioned whether HNE1 sus and 5-8F sus possessed EMT characteristics. We found that the epithelial cell markers of E-cadherin disappeared, and EMT marker vimentin increased; however, the HNE1 re-ad and 5-8F re-ad cells had no change ( Figure 2D ). These results indicated that we had successfully induced anoikis-resistant NPC cell lines. Figure 2D ), which increased the cell invasion capacity. HNE1 re-ad and 5-8F re-ad apoptosis decreased, and the anti-apoptotic ability increased ( Figure 2E,F) . However, the expression of MMP-9 and VEGF did not increase ( Figure 2D ), and the cell invasion force did not strengthen. 
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| Inhibin B attenuates EMT changes of anoikis-resistant cells
We continued to observe whether INHBB affected the EMT markers.
The study found that the expression of E-cadherin was upregulated in Anoikis resistance is essential for tumor metastasis. Tumor cells acquired metastatic characteristics by suppressing the death receptor and mitochondrial pathways. 23 We successfully induced anoikisresistant characteristics of NPC cells, compared with parental cells, in which the growth pattern changed, epithelial cells marking E-cadherin disappeared, and the mesenchymal cell marker vimentin was upregulated. These suggested that the anoikis-resistant cells led to EMT modification, and these anoikis-resistant NPC cells healed wounds at a much faster rate and were highly invasive compared to adhesion cells ( Figure S2 ). Furthermore, these EMT changes enhanced anti-apoptosis and invasion (Figure 2 ). As far as we know, the TGF-β signaling pathway is critical for EMT. During the EMT process, the polar protein could not be accurately positioned on the membrane, which could remove the blocking of Smads and promote the activation of the TGF-β signal, which preserved the stability of the EMT phenotype and the ability to resist anoikis. 38 A low dose of paraquat could induce pulmonary epithelial cell A549 EMT alteration, and the EMT-like reaction and fibrinogenesis of the cells were promoted through the TGF-β pathway. 39 Flotillin-1 could induce the expression and secretion of TGF-β1 and promote the activation of the TGF-β/Smads signaling pathway, leading to EMT changes in NPC cells. 40 The mutant p53 gene might cause the development of malignant tumors. Wild-type p53 is considered to be a cancer suppressor; p53 is transfected into tumor cells with an adenovirus as the carrier, which can inhibit tumor growth and cell proliferation. 46, 47 Furthermore, rAd-p53 combined with chemoradiotherapy for the treatment of recurrent NPC patients, which reportedly enhanced survival and provided better efficacy and lower toxicity than rAd-p53 or chemoradiotherapy alone. 48 However, mutated p53 has been suggested to switch TGF-β to a tumor impact factor. The functional switching of TGF-β is partially caused by p53 mutation or p53 inactivation during cancer progression. 49 A significant correlation existed between p53 overexpression and poor prognostic factors, an increased frequency of regional recurrence, and visceral metastasis in breast cancer patients, 50 and patients with triple-negative breast cancer showed p53 protein overexpression, which resulted in lower survival. 51 In our study, the expression of p53 was upregulated in anoikis-resistant NPC cells with highly invasive and metastatic characteristics. Inhibition of INHBB can activate TGF-β function through the interaction of TGF-β and p53, 52 which could further improve p53 levels in metastatic NPC cells ( Figure S3 ). We speculated that INHBB could achieve a good effect by downregulation of mutant p53 in the treatment of metastatic NPC patients. We will verify the hypothesis in the next study.
In conclusion, diminished INHBB can activate the TGF-β/Smads signaling pathway and promote EMT modification, enhance greater invasion and metastasis abilities in anoikis-resistant NPC cells, and further increase p53 expression. Inhibin B could be used as a candidate biomarker for the clinical progression of NPC, especially as a candidate marker for lymph node metastasis of NPC, as well as a therapeutic application.
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